By Michael Erman (Reuters) -The U.S. drug regulator authorized updated COVID-19 vaccines from Pfizer and its partner BioNTech as well as from Moderna this week as the country prepares to …
"vaccine"
-
-
(Reuters) – U.S. COVID vaccine manufacturers set list prices for their shots between $120 and $130 per dose, company executives said at an advisory panel meeting of U.S. Centers for …
-
By Rollo Ross LOS ANGELES (Reuters) – The anti-vaccination movement that flourished during the COVID-19 pandemic appears to also apply to dog owners, increasing the risk of disease for dogs, …
-
‘Americans Be Damned’: Rand Paul Goes Ballistic On Senate Floor Over Vaccine, Mask Rules Harold Hutchison on September 7, 2023 Republican Sen. Rand Paul of Kentucky slammed vaccine mandates during …
-
President Joe Biden has announced he has asked for funding from Congress to fund the rollout of a new COVID-19 vaccine starting as early as this year, adding that this …
-
TRENTON, NJ – New Jerseyans could be looking down the barrel of a new COVID-19 vaccine mandate after a comment made by President Joe Biden earlier this week. U.S. President …
-
(Reuters) – A panel of independent advisers to the Centers for Disease Control and Prevention (CDC) will meet next month to make recommendations on updated COVID-19 vaccines ahead of the …
-
Trenton, NJ – Senator Declan O’Scanlon sharply criticized the administration at Rutgers University, calling it an embarrassment, and demanded the resignation of the University’s President and leadership cabinet after they …
-
Kindergarten Vaccine Exemptions Reach All-Time High In The Last Ten Years Kate Anderson on August 24, 2023 The number of kindergarten students who have gotten an exemption from their school’s …
-
AMSTERDAM (Reuters) -Johnson & Johnson’s Janssen division, which helped to develop its single-dose COVID-19 vaccine, will close much of its vaccine research and development operations in the Netherlands, newspaper De …
-
(Reuters) – The U.S. government said on Tuesday it had awarded $1.4 billion for the development of new therapies and vaccines against COVID-19, including a $326 million contract with Regeneron …
-
By Patrick Wingrove and Bhanvi Satija (Reuters) – The U.S. Food and Drug Administration on Monday approved Pfizer’s respiratory syncytial virus (RSV) vaccine for use in women during the middle …
-
NEW BRUNSWICK, NJ – Senator Declan O’Scanlon sharply criticized Rutgers University for its ongoing COVID vaccine mandate, following the university’s announcement that it will continue to require students to provide …
-
Sen. Declan O’Scanlon sharply criticized Rutgers ongoing COVID vaccine mandate as being out of step with science and logic.
-
(Reuters) – Moderna said on Thursday an initial study data showed its updated COVID-19 vaccine to be effective against the “Eris” and “Fornax” subvariants in humans. The company expects the …
-
By Michael Erman NEW YORK (Reuters) – A new COVID vaccine is due out next month, but health experts and analysts say it is likely to be coolly received even …
-
By Jonathan Stempel NEW YORK (Reuters) -A divided federal appeals court on Friday rejected a challenge to a Connecticut law that ended the state’s decades-old religious exemptions from immunization requirements …
-
By Blake Brittain (Reuters) -British biopharmaceutical giant GSK sued Pfizer in a U.S. court on Wednesday, alleging that Pfizer’s respiratory syncytial virus (RSV) vaccine Abrysvo violates GSK’s patent rights in …
-
By Maggie Fick and Radhika Anilkumar LONDON (Reuters) -AstraZeneca on Friday delivered forecast-beating profits and sales in the second quarter as a strong performance by its blockbuster cancer drugs offset …
-
TOKYO (Reuters) -Japan’s Takeda Pharmaceutical posted first-quarter profit that beat analysts’ estimates, citing solid sales of mainstay drugs and the launch of new products including its dengue fever vaccine. The …
-
Chase Closes Prominent Vaccine Skeptic’s Business Account And Executives’ Personal Bank Accounts Jason Cohen on July 26, 2023 JPMorgan Chase canceled vaccine skeptic Dr. Joseph Mercola’s business account and the …
-
(Reuters) -Moderna and its partner Merck said on Wednesday that they had begun enrolling patients in a late-stage study testing their personalized mRNA-based skin cancer vaccine in combination with the …
-
(Reuters) -The European Union’s health regulator on Friday backed authorization of Pfizer’s vaccine for respiratory syncytial virus (RSV) for use in babies and older adults. If the European Commission authorizes …
-
(Reuters) -COVID vaccine makers should price their updated shots for the fall at a reasonable rate that would reflect the benefits they received through government investments, the U.S. Department of …
-
By Jennifer Rigby LONDON (Reuters) – Three global health bodies are teaming up to investigate stockpiling experimental vaccines for rare infectious diseases so the shots can be tested more quickly …